Evidence map›Paper›PMID 24141096›Full record

ArticleNucleic acids research2014

Highlights of the DNA cutters: a short history of the restriction enzymes.

Wil A M Loenen, David T F Dryden, Elisabeth A Raleigh, Geoffrey G Wilson, Noreen E Murray

Abstract readHistorical Article
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed.

  1. How bacterial immune systems sense phage infection.Nature reviews. Microbiology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Bacterial immune systems.Antonie van Leeuwenhoek · 2026
    Review
  11. Methylation Dynamics inMicroorganisms · 2026
    Article
  12. Genetic engineering ofMicrobial genomics · 2026
    Article
  13. Restriction-modification systems are required forProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wil A M LoenenLeiden University Medical Center, Leiden, the Netherlands, EaStChemSchool of Chemistry, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, Scotland, UK and New England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, USA.
David T F Dryden
Elisabeth A Raleigh
Geoffrey G Wilson
Noreen E Murray

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the early 1950's, 'host-controlled variation in bacterial viruses' was reported as a non-hereditary phenomenon: one cycle of viral growth on certain bacterial hosts affected the ability of progeny virus to grow on other hosts by either restricting or enlarging their host range. Unlike mutation, this change was reversible, and one cycle of growth in the previous host returned the virus to its original form. These simple observations heralded the discovery of the endonuclease and methyltransferase activities of what are now termed Type I, II, III and IV DNA restriction-modification systems. The Type II restriction enzymes (e.g. EcoRI) gave rise to recombinant DNA technology that has transformed molecular biology and medicine. This review traces the discovery of restriction enzymes and their continuing impact on molecular biology and medicine.

Indexed as

Deoxyribonucleases, Type III Site-SpecificDeoxyribonucleases, Type II Site-SpecificDeoxyribonucleases, Type I Site-SpecificDNA Modification MethylasesDNA Restriction EnzymesHistory, 20th CenturyDeoxyribonucleases, Type III Site-SpecificDeoxyribonucleases, Type II Site-SpecificDeoxyribonucleases, Type I Site-SpecificDNA Modification MethylasesDNA Restriction Enzymes

Identifiers

PMID24141096
PMCPMC3874209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.